Use access key #2 to skip to page content.
$3.74 0.59 (18.73%)
10/13/2008 4:00 PM

BioSante Pharmaceuticals, Inc. (BPAX)

CAPS Rating:
**

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

View Ticker Page (BPAX)

Results 1 - 10 of 19 :   12

Recs

4

Avatar rbcaps (< 20) Submitted: 3/09/07 2:44 AM : Outperform Start Price: $4.69 BPAX Score: 5.92

This company is making a drug to increase sex drives in women. An extremely large percentage of women have very low sex drives. This especially diminishes after menopause, and we have an aging population. This article http://www.nsti.org/press/PRsh...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar tweakie (< 20) Submitted: 2/05/08 2:46 AM : Underperform Start Price: $3.83 BPAX Score: -20.20

Why the heck did the CEO write to Adam Feuerstein??? Poor leadership.

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar BrianRuth (99.72) Submitted: 3/06/08 2:18 AM : Underperform Start Price: $5.75 BPAX Score: 5.19

I hope their sexygel works. I really do. But someone needs to be on the red thumb side of this stock and call (Penn & Teller) bull$#!*.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar dstation (< 20) Submitted: 3/06/07 10:52 AM : Outperform Start Price: $4.40 BPAX Score: 9.57

One word--Libigel

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar tibber61 (86.21) Submitted: 3/28/07 9:28 PM : Outperform Start Price: $4.98 BPAX Score: 2.10

Unlike most bio firms, tech research companies focused on delivery systems seem to yield larger "hits" than "misses" by applying their discoveries over broader markets; most traditional biotechs seem to have too narrow a focus, leading to significant...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar letsmakesomemone (< 20) Submitted: 7/28/08 1:31 PM : Outperform Start Price: $5.40 BPAX Score: -13.74

A biopharmaceutical company which develops hormone therapy products to treat men and women. It is also engaged in the development of its proprietary calcium phosphate nanotechnology for aesthetic medicine, novel vaccines and drug delivery.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar EclecticRecluse (75.10) Submitted: 10/02/08 9:42 AM : Underperform Start Price: $4.38 BPAX Score: 5.44

Extremely High Price for Sales

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar pranilbalram (57.11) Submitted: 6/19/08 4:21 PM : Outperform Start Price: $5.45 BPAX Score: -9.06

Nice pipeline of products and exhibits the potential for a buyout. Very high debt ratio so the risk is high, however, strong working capital is present.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar KBroodie1 (59.72) Submitted: 6/13/08 11:28 AM : Outperform Start Price: $5.60 BPAX Score: -9.21

They will improve overtime

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Derrickmarshall (21.70) Submitted: 6/11/08 12:46 AM : Outperform Start Price: $4.31 BPAX Score: 10.12

Possible buyout target

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners